02235 微泰醫療-B
公司資料 - 股權變動
日期 股東名稱 披露原因 買入/賣出涉及
的股份數目
每股平均價 持有權益的
股份數目
佔已發行
股本(%)
26/11/2025OrbiMed Advisors V Limited1101(L)+1,450,600(L)24,260,100(L)14.34
26/11/2025OrbiMed Asia GP V, L.P.1101(L)+1,450,600(L)24,260,100(L)14.34
26/11/2025OrbiMed Asia Partners V, L.P.1101(L)+1,450,600(L)24,260,100(L)14.34
24/11/2025鄭攀1213(L)-10,530,757(L)71,478,780(L)34.33
24/11/2025施永辉1113(L)+2,123,320(L)2,123,320(L)1.02
24/11/2025杭州研泰投資合夥企業(有限合夥)1704(L)2,157,409(L)1.04
24/11/2025劉秀1113(L)+642,885(L)642,885(L)0.31
24/11/2025于非1113(L)+2,269,008(L)2,269,008(L)1.09
19/11/2025OrbiMed Advisors V Limited1101(L)+2,090,000(L)22,760,100(L)13.45
19/11/2025OrbiMed Asia GP V, L.P.1101(L)+2,090,000(L)22,760,100(L)13.45
19/11/2025OrbiMed Asia Partners V, L.P.1101(L)+2,090,000(L)22,760,100(L)13.45
19/11/2025鄭攀1201(L)-2,090,000(L)HKD 6.900(L)38,700,719(L)22.88
13/11/2025OrbiMed Asia Partners V, L.P.1101(L)+900,000(L)20,670,100(L)12.22
13/11/2025OrbiMed Asia GP V, L.P.1101(L)+900,000(L)20,670,100(L)12.22
13/11/2025OrbiMed Advisors V Limited1101(L)+900,000(L)20,670,100(L)12.22
13/11/2025鄭攀1201(L)-900,000(L)HKD 6.040(L)40,790,719(L)24.11
12/09/2025CDBI Partners Fund II, L.P.1201(L)-93,200(L)HKD 8.610(L)8,396,831(L)4.96
12/09/2025CD Capital Healthcare FUND V, L.P.1201(L)-93,200(L)HKD 8.610(L)8,396,831(L)4.96
12/09/2025CD Capital GP Ltd1201(L)-93,200(L)HKD 8.610(L)8,396,831(L)4.96
12/09/2025CDBI Partners Fund I, L.P.1201(L)-93,200(L)HKD 8.610(L)8,396,831(L)4.96
12/09/2025CDBI GP, Ltd1201(L)-93,200(L)HKD 8.610(L)8,396,831(L)4.96
12/09/2025CDBI Partners GP, Ltd1201(L)-93,200(L)HKD 8.610(L)8,396,831(L)4.96
12/09/2025Master Summer Limited1201(L)-93,200(L)HKD 8.610(L)8,396,831(L)4.96
16/05/2025Qiming Venture Partners V, L.P.1201(L)-6,956,748(L)15,190,018(L)34.76
16/05/2025QM32 Limited1201(L)-6,956,748(L)15,190,018(L)34.76
16/05/2025Qiming GP V, L.P.1201(L)-6,956,748(L)15,190,018(L)34.76
16/05/2025Qiming Corporate GP V, Ltd.1201(L)-6,956,748(L)15,190,018(L)34.76
08/05/2025Suzhou Qicheng Investment Management Partnership (Limited Partnership)1201(L)-5,043,252(L)11,011,913(L)5.29
08/05/2025于佳1201(L)-5,043,252(L)11,011,913(L)5.29
08/05/2025Suzhou Qiming Ronghe Venture Capital Partnership (Limited Partnership)1201(L)-5,043,252(L)11,011,913(L)5.29
08/05/2025Shanghai Qichang Investment Consulting Co., Ltd.1201(L)-5,043,252(L)11,011,913(L)5.29
08/05/2025胡旭波1201(L)-5,043,252(L)11,011,913(L)5.29
22/04/2025LAV Kecheng Hong Kong Limited1001(L)+3,000,000(L)3,000,000(L)6.87
22/04/2025LAV Corporate VI GP Opportunities, Ltd.1001(L)+3,000,000(L)3,000,000(L)6.87
22/04/2025LAV Fund VI Opportunities, L.P.1001(L)+3,000,000(L)3,000,000(L)6.87
22/04/2025LAV GP VI Opportunities, L.P.1001(L)+3,000,000(L)3,000,000(L)6.87
22/04/2025Shanghai Liyao Investment Management Co., Ltd (上海礼曜投资管理有限公司)1101(L)24,776,804(L)11.90
22/04/2025陈飞1101(L)24,776,804(L)11.90
22/04/2025施毅1101(L)+3,000,000(L)20,091,680(L)45.98
07/03/2025OrbiMed Advisors V Limited1101(L)+4,589,900(L)HKD 4.990(L)19,651,800(L)11.61
 1    2  
備註: (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。
  (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.